Latest News
These are CLL Ireland’s latest news posts from Facebook – but make sure to visit our CLL Ireland Facebook page for older posts.
Interesting research for patients taking ibrutinib
BTK mutations linked to CLL progression on ibrutinib
The findings support mutational analysis in CLL patients on ibrutinib, according to researchers.BTK mutations linked to CLL progression on ibrutinib
BTK mutations linked to CLL progression on ibrutinib
The findings support mutational analysis in CLL patients on ibrutinib, according to researchers.We offer our heartfelt condolences to Barry McGuigan and his family tonight on the death of his daughter Danika. We had the opportunity to work with Barry in the past and he is a stalwart advocate for patients with blood cancer, he is in our thoughts at this difficult time.
Actress Nika McGuigan dies aged 33
Actress Danika McGuigan, daughter of former boxing champion Barry McGuigan, has died aged 33 following a short illness.Ibrutinib-venetoclax found highly active in hard-to-treat CLL
Ibrutinib-venetoclax found highly active in hard-to-treat CLL
Trial results suggest the two drugs may have synergistic efficacy when used together, and raise the possibility of achieving MRD negativity with limited-duration therapy.For those intolerant of, or unresponsive to, treatment with Ibrutinib and other BCR inhibitors or BCL-2 inhibitors this study is very interesting... via Lymphoma News Today
ow.ly/T6WK30p7zHj
Dosing Begins in Advanced CLL and SLL Patients in Study of TP-0903 Given With or Without Imbruvica
A Phase 1/2 trial, still enrolling, will evaluate TP-0903, an oral inhibitor of AXL, alone or with Imbruvica in previously treated CLL and SLL patients.Timeline PhotosToday we are launching our Budget 2020 submission, calling on the Government to reduce the huge financial strain on cancer patients and their families.
Our Chief Executive Averil Power says, “Many families suffer a big drop in income when someone gets cancer. At the same time, they have to pay for everything from chemotherapy appointments to anti-nausea medication and hospital parking charges. With extra costs of up to €1,200 a month, they find themselves under siege financially while also trying to manage the physical and psychological burden of having cancer.”
In Budget 2020 the Society is calling for:
- The removal of inpatient charges
- A reduction in the Drugs Payment Scheme threshold
- The removal of the prescription charge for medical card holders
- Reduced hospital parking charges for frequent visitors.
Learn more about our Budget 2020 submission: www.cancer.ie/about-us/news/irish-cancer-society-calls-government-reduce-financial-burden-patient...
Since skin cancer is a common secondary cancer for some CLL’ers please take note of this advice on these sunnier days!
www.independent.ie/life/health-wellbeing/5-common-myths-about-sunscreen-and-the-facts-thatll-prot...
5 common myths about sunscreen, and the facts that'll protect your skin
As a nation that's used to rainy, dull weather, it's no surprise that us Irish love to flock to the beach and lay out in the sun the minute it makes an appearance.Our own Irish CLL expert, Professor Patrick Thornton speaking last weekend at EHA.
www.vjhemonc.com/video/2a72prbpmhc-major-cll-updates-from-eha-2019/
Major CLL updates from EHA 2019 | VJHemOnc
Patrick Thornton, MD, Beaumont Hospital, Dublin, Ireland, tells us about some of the excellent chronic lymphocytic leukemia (CLL) updates presented...Futureoroof Extra: CAR-T | Newstalk
Futureoroof Extra: CAR-T | Newstalk
Cellular immunotherapy is one of the most exciting developments in cancer treatment this decade....EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia. ecancer - News
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed or refractory chronic lymphocytic leukaemia (CLL) has been presented at the 2019 European Hematology Association (EHA) Annual Meeting.
